S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook

Olema Pharmaceuticals (OLMA) Insider Trading & Ownership

$9.90
-0.81 (-7.56%)
(As of 04/18/2024 ET)

Olema Pharmaceuticals (NASDAQ:OLMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
23.50%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$17.85 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$3.16 M
Get OLMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OLMA Insider Buying and Selling by Quarter

Olema Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/28/2024Cyrus HarmonDirectorSell20,000$10.97$219,400.00  
2/29/2024Cyrus HarmonDirectorSell25,000$12.41$310,250.00  
1/31/2024Cyrus HarmonDirectorSell25,000$12.23$305,750.00  
12/6/2023Biocapital Advisors L ParadigmMajor ShareholderBuy100,000$11.60$1,160,000.00  
12/5/2023G. Walmsley GrahamDirectorBuy131,870$14.19$1,871,235.30  
11/30/2023Cyrus HarmonDirectorSell25,000$12.57$314,250.00  
11/21/2023Cyrus HarmonDirectorSell4,192$14.86$62,293.12  
11/21/2023Naseem ZojwallaInsiderSell7,461$14.84$110,721.24  
11/21/2023Sean BohenCEOSell29,293$14.88$435,879.84  
11/8/2023David C MylesInsiderSell200$17.61$3,522.00  
11/3/2023David C MylesInsiderSell541$17.51$9,472.91  
11/2/2023Cyrus HarmonDirectorSell5,000$15.64$78,200.00  
11/1/2023David C MylesInsiderSell6,668$15.02$100,153.36  
10/31/2023Cyrus HarmonDirectorSell25,000$12.05$301,250.00  
9/29/2023Cyrus HarmonDirectorSell25,000$12.41$310,250.00  
9/19/2023David C MylesInsiderSell20,000$12.67$253,400.00  
9/12/2023Bvf Partners L P/IlDirectorBuy1,505,932$9.84$14,818,370.88  
9/5/2023Cyrus HarmonDirectorSell10,000$11.62$116,200.00  
8/31/2023Cyrus HarmonDirectorSell15,000$9.36$140,400.00  
6/8/2023Cyrus HarmonDirectorSell10,000$6.30$63,000.00  
6/5/2023Cyrus HarmonDirectorSell5,000$6.04$30,200.00  
(Data available from 1/1/2013 forward)

OLMA Insider Trading Activity - Frequently Asked Questions

Who is on Olema Pharmaceuticals's Insider Roster?

The list of insiders at Olema Pharmaceuticals includes Biocapital Advisors L Paradigm, Bvf Partners L P/Il, Cyrus Harmon, David C Myles, G. Walmsley Graham, Kinney Horn, Naseem Zojwalla, and Sean Bohen. Learn more on insiders at OLMA.

What percentage of Olema Pharmaceuticals stock is owned by insiders?

23.50% of Olema Pharmaceuticals stock is owned by insiders. Learn more on OLMA's insider holdings.

Which Olema Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($1,160,000.00), Bvf Partners L P/Il ($15,624,370.88), and G. Walmsley Graham ($1,871,235.30).

How much insider buying is happening at Olema Pharmaceuticals?

Insiders have purchased a total of 1,937,802 OLMA shares in the last 24 months for a total of $18,655,606.18 bought.

Which Olema Pharmaceuticals insiders have been selling company stock?

The following insiders have sold OLMA shares in the last 24 months: Cyrus Harmon ($2,251,443.12), David C Myles ($366,548.27), Naseem Zojwalla ($110,721.24), and Sean Bohen ($435,879.84).

How much insider selling is happening at Olema Pharmaceuticals?

Insiders have sold a total of 258,355 Olema Pharmaceuticals shares in the last 24 months for a total of $3,164,592.47 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:OLMA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners